Ira Targoff is a Rheumatology/Immunology physician affiliated with University of Oklahoma Health Sciences Center. OpenAlex indexes 140 publications with 10,730 citations (h-index 58).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
825 NE 10th St
Oupb 2300
Oklahoma City, OK 731045417
Telephone
405-271-8478Registry record last updated 16 Mar 2011.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20241 payment
- Amgen Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
40.7%Corticosteroid27.1%Prednisone100%Part D<11 patientsAminosalicylate13.6%Sulfasalazine100%Part D<11 patientsCancer & immunology
32.2%Folate Analog Metabolic Inhibitor13.6%Methotrexate100%Part D<11 patientsTNF inhibitor9.3%Enbrel Sureclick100%Part D<11 patients+ 1 more class in this area
Respiratory
16.1%Opioid Agonist16.1%Hydrocodone-Acetaminophen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1985–1993 per NIH RePORTER. The latest:
- MOLECULAR ANALYSIS OF POLYMYOSITIS-ASSOCIATED ANTIGENS
Oklahoma Medical Research Foundation
FY1992P01AI021568 - CORE--PATIENT ACCRUAL AND HLA SEROLOGICAL ANALYSIS
Oklahoma Medical Research Foundation
FY1992P01AI021568
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis
Annals of the Rheumatic Diseases
2019 - Early Illness Features Associated With Mortality in the Juvenile Idiopathic Inflammatory Myopathies
Arthritis Care & Research
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Harold Burkhart, MD
University of Oklahoma Health Sciences Center
Steven Chernausek, MD
University of Oklahoma Health Sciences Center
Udho Thadani, MD
University of Oklahoma Health Sciences Center
Michael Bronze, MD
University of Oklahoma Health Sciences Center
Marc Hochberg, MD
University of Maryland School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Dinesh Khanna, MD
University of Michigan
Matthew Liang, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”